Skip to main content
SpringerLink
Log in

Pulling away from the pack in drug launches

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Trends in drug launch performance.
Figure 2: Trends in factors affecting launch success.

Acknowledgements

The authors would like to acknowledge R. Linden, N. Husain, C. Eakins, F. Yu and J. Mong for help with this research.

Author information

Authors and Affiliations

  1. McKinsey & Company, 315 Montgomery Street, San Francisco, 94104, California, USA

    Nicholas Donoghoe

  2. McKinsey & Company, 3075 Hansen Way, Palo Alto, 94304, California, USA

    Jon Duane & George Xu

  3. McKinsey & Company, 2000 Avenue of the Stars, Suite 800N, Los Angeles, 90067, California, USA

    Jin Kim

Authors
  1. Nicholas Donoghoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jon Duane
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Nicholas Donoghoe or Jin Kim.

Ethics declarations

Competing interests

The authors of this article are employees of McKinsey & Company, a management consultancy that works with the world's leading biopharmaceutical companies on launch issues. The analysis in this study was funded by McKinsey's Pharmaceuticals and Medical Products practice.

Supplementary information

Supplementary information S1 (box)

Data and analysis (PDF 214 kb)

Supplementary information S2 (figure)

Winners are pulling further ahead in oncology and other therapeutic areas (PDF 89 kb)

Supplementary information S3 (figure)

Companies that are more selective in early clinical development tend to have better launches (PDF 101 kb)

Supplementary information S4 (figure)

Launch success factors differ for oncology and central nervous system (CNS) drugs (PDF 274 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donoghoe, N., Duane, J., Kim, J. et al. Pulling away from the pack in drug launches. Nat Rev Drug Discov 16, 749–750 (2017). https://doi.org/10.1038/nrd.2017.122

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.122

  • Springer Nature Limited

Search

Navigation